Latest filings (excl ownership)
ARS
2023 FY
Annual report to shareholders
29 Apr 24
DEFA14A
Additional proxy soliciting materials
29 Apr 24
DEF 14A
Definitive proxy
29 Apr 24
PRE 14A
Preliminary proxy
19 Apr 24
S-8
Registration of securities for employees
27 Mar 24
10-K
2023 FY
Annual report
27 Mar 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
26 Mar 24
8-K
Gyre Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
25 Mar 24
8-K
Gyre Therapeutics Expands Board of Directors with Appointment of Rodney L. Nussbaum
21 Mar 24
8-K
Results of Operations and Financial Condition
14 Feb 24
8-K/A
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
19 Jan 24
8-K/A
Completion of Acquisition or Disposition of Assets
12 Jan 24
8-K
Departure of Directors or Certain Officers
15 Dec 23
8-K
Regulation FD Disclosure
6 Dec 23
RW
Registration withdrawal request
29 Nov 23
8-K
Regulation FD Disclosure
14 Nov 23
D
$5.00 mm in equity / options, sold $5.00 mm, 1 investor
13 Nov 23
8-K
Gyre Therapeutics Presents Poster at the American Association for the Study of Liver Diseases (AASLD) Annual Liver Meeting
13 Nov 23
S-3
Shelf registration
9 Nov 23
8-K
Regulation FD Disclosure
6 Nov 23
8-K
Changes in Registrant's Certifying Accountant
2 Nov 23
424B3
Prospectus supplement
1 Nov 23
S-8
Registration of securities for employees
30 Oct 23
8-K
Entry into a Material Definitive Agreement
30 Oct 23
EFFECT
Notice of effectiveness
30 Oct 23
8-K
Regulation FD Disclosure
27 Oct 23
424B3
Prospectus supplement
27 Oct 23
10-Q
2023 Q3
Quarterly report
26 Oct 23
S-3/A
Shelf registration (amended)
24 Oct 23
CORRESP
Correspondence with SEC
24 Oct 23
8-K
Other Events
20 Oct 23
S-3/A
Shelf registration (amended)
13 Oct 23
CORRESP
Correspondence with SEC
13 Oct 23
8-K
Entry into a Material Definitive Agreement
31 Aug 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
8-K
Results of Operations and Financial Condition
14 Aug 23
UPLOAD
Letter from SEC
3 Aug 23
S-3
Shelf registration
24 Jul 23
DEFM14A
Proxy related to merger
20 Jul 23
UPLOAD
Letter from SEC
20 Jul 23
Latest ownership filings
4
NASSIM USMAN
2 May 24
144
Notice of proposed sale of securities
1 May 24
144
Notice of proposed sale of securities
9 Apr 24
144
Notice of proposed sale of securities
8 Apr 24
144
Notice of proposed sale of securities
5 Apr 24
144
Notice of proposed sale of securities
4 Apr 24
144
Notice of proposed sale of securities
3 Apr 24
4
NASSIM USMAN
3 Apr 24
144
Notice of proposed sale of securities
2 Apr 24
144
Notice of proposed sale of securities
1 Apr 24
4
Rodney L Nussbaum
21 Mar 24
3
Rodney L Nussbaum
21 Mar 24
4
NASSIM USMAN
19 Mar 24
144
Notice of proposed sale of securities
15 Mar 24
SC 13G/A
LYTTON LAURENCE W
14 Feb 24
SC 13D/A
GNI Group Ltd.
24 Jan 24
SC 13D/A
GNI Group Ltd.
27 Nov 23
4
Ying Luo
22 Nov 23
4
Weiguo Ye
22 Nov 23
4
Songjiang Ma
22 Nov 23
4
Ruoyu Chen
22 Nov 23
4
Change in insider ownership
22 Nov 23
4
Charles C Wu
22 Nov 23
3/A
Songjiang Ma
22 Nov 23
SC 13D/A
GNI Group Ltd.
1 Nov 23
4
Ying Luo
1 Nov 23
4
Thomas Wilson Eastling
1 Nov 23
4
Renate Parry
1 Nov 23
4
Ruoyu Chen
1 Nov 23
4
NASSIM USMAN
1 Nov 23
4
Han Ying
1 Nov 23
4
Gordon Carmichael
1 Nov 23
3
Songjiang Ma
1 Nov 23
3
Renate Parry
1 Nov 23
3
Han Ying
1 Nov 23
3
Gordon Carmichael
1 Nov 23
3
Weiguo Ye
1 Nov 23
3
Ruoyu Chen
1 Nov 23
3
Charles C Wu
1 Nov 23
4
Change in insider ownership
31 Oct 23